The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Extracorporeal Membrane Oxygenation in the Therapy of Cardiogenic Shock: Results of the ECMO-CS Randomized Clinical Trial
Abstract
Background: Veno-arterial extracorporeal membrane oxygenation (VA-ECMO) is increasingly being used for circulatory support in patients with cardiogenic shock, although the evidence supporting its use in this context remains insufficient. The ECMO-CS trial (Extracorporeal Membrane Oxygenation in the Therapy of Cardiogenic Shock) aimed to compare immediate implementation of VA-ECMO versus an initially conservative therapy (allowing downstream use of VA-ECMO) in patients with rapidly deteriorating or severe cardiogenic shock. Methods: This multicenter, randomized, investigator-initiated, academic clinical trial included patients with either rapidly deteriorating or severe cardiogenic shock. Patients were randomly assigned to immediate VA-ECMO or no immediate VA-ECMO. Other diagnostic and therapeutic procedures were performed as per current standards of care. In the early conservative group, VA-ECMO could be used downstream in case of worsening hemodynamic status. The primary end point was the composite of death from any cause, resuscitated circulatory arrest, and implementation of another mechanical circulatory support device at 30 days. Results: A total of 122 patients were randomized; after excluding 5 patients because of the absence of informed consent, 117 subjects were included in the analysis, of whom 58 were randomized to immediate VA-ECMO and 59 to no immediate VA-ECMO. The composite primary end point occurred in 37 (63.8%) and 42 (71.2%) patients in the immediate VA-ECMO and the no early VA-ECMO groups, respectively (hazard ratio, 0.72 [95% CI, 0.46–1.12]; P =0.21). VA-ECMO was used in 23 (39%) of no early VA-ECMO patients. The 30-day incidence of resuscitated cardiac arrest (10.3.% versus 13.6%; risk difference, –3.2 [95% CI, –15.0 to 8.5]), all-cause mortality (50.0% versus 47.5%; risk difference, 2.5 [95% CI, –15.6 to 20.7]), serious adverse events (60.3% versus 61.0%; risk difference, –0.7 [95% CI, –18.4 to 17.0]), sepsis, pneumonia, stroke, leg ischemia, and bleeding was not statistically different between the immediate VA-ECMO and the no immediate VA-ECMO groups. Conclusions: Immediate implementation of VA-ECMO in patients with rapidly deteriorating or severe cardiogenic shock did not improve clinical outcomes compared with an early conservative strategy that permitted downstream use of VA-ECMO in case of worsening hemodynamic status. Registration: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT02301819.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure
McDonagh, T. A., Metra, M., Adamo, M., Gardner, R. S., Baumbach, A., Böhm, M., Burri, H., Butler, J., Čelutkienė, J., Chioncel, O., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab368 · Cited by 13,344
Self-citationEarly Revascularization in Acute Myocardial Infarction Complicated by Cardiogenic Shock
Hochman, J. S., Sleeper, L. A., Webb, J. G., Sanborn, T. A., White, H. D., Talley, J. D., Buller, C. E., Jacobs, A. K., Slater, J. N., Col, J., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199908263410901 · Cited by 3,131
Intraaortic Balloon Support for Myocardial Infarction with Cardiogenic Shock
Thiele, H., Zeymer, U., Neumann, F.-J., Ferenc, M., Olbrich, H.-G., Hausleiter, J., Richardt, G., Hennersdorf, M., Empen, K., Fuernau, G., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1208410 · Cited by 2,861
PCI strategies in patients with acute myocardial infarction and cardiogenic shock
Thiele, H., Akin, I., Sandri, M., Fuernau, G., de Waha, S., Meyer-Saraei, R., Nordbeck, P., Geisler, T., Landmesser, U., Skurk, C., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1710261 · Cited by 1,209
Extracorporeal Life Support Organization Registry International Report 2016
Thiagarajan, R. R., Barbaro, R. P., Rycus, P. T., Mcmullan, D. M., Conrad, S. A., Fortenberry, J. D., & Paden, M. L. (2017) · ASAIO Journal · doi:10.1097/mat.0000000000000475 · Cited by 903
Naidu, S. S., Baran, D. A., Jentzer, J. C., Hollenberg, S. M., van Diepen, S., Basir, M. B., Grines, C. L., Diercks, D. B., Hall, S., Kapur, N. K., et al. (2022) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2022.01.018 · Cited by 748
Ouweneel, D. M., Schotborgh, J. V., Limpens, J., Sjauw, K. D., Engström, A. E., Lagrand, W. K., Cherpanath, T. G. V., Driessen, A. H. G., de Mol, B. A. J. M., & Henriques, J. P. S. (2016) · Intensive Care Medicine · doi:10.1007/s00134-016-4536-8 · Cited by 538
Henry, T. D., Tomey, M. I., Tamis-Holland, J. E., Thiele, H., Rao, S. V., Menon, V., Klein, D. G., Naka, Y., Piña, I. L., Kapur, N. K., et al. (2021) · Circulation · doi:10.1161/cir.0000000000000959 · Cited by 276
Geller, B. J., Sinha, S. S., Kapur, N. K., Bakitas, M., Balsam, L. B., Chikwe, J., Klein, D. G., Kochar, A., Masri, S. C., Sims, D. B., et al. (2022) · Circulation · doi:10.1161/cir.0000000000001076 · Cited by 274
Sy, E., Sklar, M. C., Lequier, L., Fan, E., & Kanji, H. D. (2017) · Journal of Critical Care · doi:10.1016/j.jcrc.2017.02.014 · Cited by 213
Cited by
2023 ESC Guidelines for the management of acute coronary syndromes
Byrne, R. A., Rossello, X., Coughlan, J. J., Barbato, E., Berry, C., Chieffo, A., Claeys, M. J., Dan, G.-A., Dweck, M. R., Galbraith, M., et al. (2023) · European Heart Journal · doi:10.1093/eurheartj/ehad191 · Cited by 5,333
Self-citationExtracorporeal Life Support in Infarct-Related Cardiogenic Shock
Thiele, H., Zeymer, U., Akin, I., Behnes, M., Rassaf, T., Mahabadi, A. A., Lehmann, R., Eitel, I., Graf, T., Seidler, T., et al. (2023) · New England Journal of Medicine · doi:10.1056/nejmoa2307227 · Cited by 799
Rao, S. V., O’Donoghue, M. L., Ruel, M., Rab, T., Tamis-Holland, J. E., Alexander, J. H., Baber, U., Baker, H., Cohen, M. G., Cruz-Ruiz, M., et al. (2025) · Circulation · doi:10.1161/cir.0000000000001309 · Cited by 625
2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes
Rao, S. V., O’Donoghue, M. L., Ruel, M., Rab, T., Tamis-Holland, J. E., Alexander, J. H., Baber, U., Baker, H., Cohen, M. G., Cruz-Ruiz, M., et al. (2025) · JACC · doi:10.1016/j.jacc.2024.11.009 · Cited by 552
2023 ESC Guidelines for the management of acute coronary syndromes
Byrne, R. A., Rossello, X., Coughlan, J. J., Barbato, E., Berry, C., Chieffo, A., Claeys, M. J., Dan, G.-A., Dweck, M. R., Galbraith, M., et al. (2024) · European Heart Journal: Acute Cardiovascular Care · doi:10.1093/ehjacc/zuad107 · Cited by 314
Self-citation
Metadata
- Authors
- Ostadal, P., Rokyta, R., Karasek, J., Kruger, A., Vondrakova, D., Janotka, M., Naar, J., Smalcova, J., Hubatova, M., Hromadka, M., Volovar, S., Seyfrydova, M., Jarkovsky, J., Svoboda, M., Linhart, A., Belohlavek, J., & for the ECMO-CS Investigators
- Venue
- Circulation
- Published
- 2023-02-07
- Volume
- 147
- Issue
- 6
- Pages
- 454-464
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W4308294266
- Cited by
- 497
- References
- 21
- FWCI
- 28.00
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Extracorporeal Membrane Oxygenation in the Therapy of Cardiogenic Shock: Results of the ECMO-CS Randomized Clinical Trial. https://app.cochat.ai/papers/10.1161/circulationaha.122.062949
- The paper
- Ostadal, P., Rokyta, R., Karasek, J., Kruger, A., Vondrakova, D., Janotka, M., Naar, J., Smalcova, J., Hubatova, M., Hromadka, M., Volovar, S., Seyfrydova, M., Jarkovsky, J., Svoboda, M., Linhart, A., Belohlavek, J., & for the ECMO-CS Investigators. (2023). Extracorporeal Membrane Oxygenation in the Therapy of Cardiogenic Shock: Results of the ECMO-CS Randomized Clinical Trial. Circulation. https://doi.org/10.1161/circulationaha.122.062949
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.